Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2026-06-05EMA Application withdrawn: Insulin Aspart Injection (insulin aspart) — Masuu Pharma Europe Limited
The EMA withdrew the application for insulin aspart injection by Masuu Pharma Europe Limited.
-
CLINICAL_TRIALS withdrawal · 2026-02-17Clinical Trial Update: Towards Optimal Screening and Management of Coronary Artery Disease in Diabetes: TOSCANA Study
The TOSCANA study, sponsored by the French Cardiology Society, investigating optimal screening and management of coronary artery disease in …
-
CLINICAL_TRIALS withdrawal · 2025-12-30Clinical Trial Update: Gamification to Increase Mobility in the Hospital [NA]
The clinical trial NCT04300764 evaluating gamification to increase mobility in hospitalized patients has been withdrawn. The sponsor is the …
-
CLINICAL_TRIALS withdrawal · 2025-12-03Clinical Trial Update: Preoperative Evaluation of Gastric Contents by Antral Ultrasound in Diabetic Patients
A clinical trial evaluating preoperative evaluation of gastric contents by antral ultrasound in diabetic patients has been withdrawn.
-
EMA withdrawal · 2025-10-22EMA Application withdrawn: Insulin Human Rechon (Insulin human) — Rechon Life Science AB
The EMA has withdrawn the marketing authorization application for Insulin Human Rechon (insulin human) by Rechon Life Science AB for diabete…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2025-10-02Clinical Trial Update: MA-CEAL Community Health Ambassador Program [NA]
Boston Medical Center has withdrawn the MA-CEAL Community Health Ambassador Program trial (NCT07136402). The study targeted hypertension and…
-
CLINICAL_TRIALS withdrawal · 2025-06-13Clinical Trial Update: Diabetes Prevention and Education [NA]
The clinical trial update indicates a University of Maryland, Baltimore-sponsored study on diabetes prevention and education has been withdr…
-
CLINICAL_TRIALS withdrawal · 2025-06-13Clinical Trial Update: Hangzhou Hospital Staff Cohort
A clinical trial involving Hangzhou Hospital staff has been withdrawn; the sponsor is Westlake University and the trial concerned diabetes m…
-
CLINICAL_TRIALS withdrawal · 2025-06-05Clinical Trial Update: A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Diabetes Mellitus
A non-interventional pilot study sponsored by ProgenaBiome to explore the role of gut flora in diabetes mellitus, including Type 2 diabetes …
-
CLINICAL_TRIALS withdrawal · 2025-05-16Clinical Trial Update: Precision Medicine Approach to Unravel the Risk Factors for Renal, Cardiovascular, Ophthalmologic, Neurologic and Hepatic Complications of Metabolic Disorders
A precision medicine trial investigating risk factors for renal, cardiovascular, ophthalmologic, neurologic and hepatic complications of met…
-
CLINICAL_TRIALS withdrawal · 2025-05-02Clinical Trial Update: Dynamics of Insulin Absorption in Subclinical Lipohypertrophy Using the Euglycemic Clamp Technique [NA]
A clinical trial investigating insulin absorption dynamics in subclinical lipohypertrophy using an euglycemic clamp has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-04-08Clinical Trial Update: Validation of the Diabetes Deep Neural Network Score for Diabetes Mellitus Screening [NA]
The clinical trial validating a Diabetes Deep Neural Network Score for diabetes screening has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-04-01Clinical Trial Update: Pharmaceutical Consultation and Exchange Between the Pharmacy and the Hospital
The clinical trial NCT04811183 studying pharmaceutical consultation and exchange between the pharmacy and the hospital for diabetes care has…
-
CLINICAL_TRIALS withdrawal · 2025-02-10Clinical Trial Update: Food Assistance, Diabetes, and HIV
The clinical trial NCT04045184 sponsored by the University of Alabama at Birmingham, studying the impact of food assistance on diabetes mell…
-
CLINICAL_TRIALS withdrawal · 2024-11-26Clinical Trial Update: CGM/Clarity Use, Glycemic Control and Clinical Outcomes [NA]
A University of Maryland-sponsored clinical trial evaluating CGM/Clarity use and glycemic outcomes in diabetes has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-09-23Clinical Trial Update: Improving Function, Quality of Life, Glycemia in Diabetics With Dementia [Phase 4]
A Phase 4 trial investigating whether improving function, quality of life, and glycemic control in people with diabetes and dementia has bee…
-
EMA withdrawal · 2023-04-20EMA Withdrawn: Inpremzia (insulin human (rDNA)) — Baxter Holding B.V.
EMA has withdrawn Inpremzia, an insulin human (rDNA) product, from the market in the European Union.
-
CLINICAL_TRIALS withdrawal · 2022-05-10Clinical Trial Update: Polydiuretic Therapy for Heart Failure With Preserved Ejection Fraction and Diabetes Mellitus [Phase 4]
A Phase 4 trial evaluating Polydiuretic Therapy for heart failure with preserved ejection fraction and diabetes mellitus has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2020-09-03Clinical Trial Update: Phase 4 Study of the Efficacy of Losartan Based Therapy in Hypertensives With and Without Diabetes [Phase 4]
Phase 4 study investigating losartan-based therapy in hypertensive patients, with and without diabetes, has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2020-09-02Clinical Trial Update: Functional Improvement of Progenitor Cells and Endothelial Function by Vildagliptin in Diabetes Mellitus (FINNjA-DM). [Phase 2, Phase 3]
A Phase 2/3 trial evaluating vildagliptin for functional improvement of progenitor cells and endothelial function in diabetes mellitus has b…
-
CLINICAL_TRIALS withdrawal · 2020-07-15Clinical Trial Update: A Single Center Study to Evaluate Ticagrelor Mechanism of Action in Inhibiting Juvenile Platelet ADP Response [Phase 4]
A Phase 4 clinical trial investigating ticagrelor's mechanism of action in inhibiting juvenile platelet ADP response has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2020-04-08Clinical Trial Update: Study in Diabetes Mellitus Patients Without Prior Myocardial Infarction or Stroke Undergoing Elective Percutaneous Coronary Intervention. [Phase 3]
Phase 3 study in diabetes patients undergoing PCI was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-07-24Clinical Trial Update: Effect of Intracameral Dexamethasone After Phacoemulsification in Diabetics on Corneal Endothelial Cell Density [Phase 4]
Phase 4 clinical trial investigating intracameral dexamethasone after cataract surgery in diabetics was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-07-24Clinical Trial Update: Pharmacokinetics of Antiplatelet Drugs in Diabetic pAtients [Phase 4]
A Phase 4 pharmacokinetics trial of antiplatelet drugs in diabetic patients was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-04-29Clinical Trial Update: Renal Effects of Three Iodinated Contrast Media (CM) in Patients at Risk Undergoing Coronary Angiography [Phase 4]
A Phase 4 trial evaluating renal effects of three iodinated contrast media in patients at risk undergoing coronary angiography has been with…